SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience Initiates Clinical Development of Antiviral Nasal Spray for Prevention of COVID-19

2022.04.13
SK bioscience Submits Post Approval Change Application of Protein-Based COVID-19 Vaccine for Adolescent Authorization to KMFDS

2022. 04. 07
SK bioscience Submits Rolling Review of Nuvaxovid for Adolescent Authorization to KMFDS

2022.03.23
SK bioscience Announces Commencement of Booster Trial of Adjuvanted COVID-19 Vaccine Candidate ‘GBP510(AS03)’ in South Korea

2022. 03. 22
SK bioscience Begins Shipment of First Authorized Protein-Based COVID-19 Vaccine

2022. 02. 09
SK bioscience Complete Recruitment for Phase III Clinical Trial of COVID-19 Vaccine

2022. 01. 18
SK bioscience Obtained Biologics License Application Approval of Novavax’ COVID-19 Vaccine in Korea

2022. 01. 12
SK bioscience-Novavax Extend Collaboration and Contract Manufacturing Agreements of COVID-19 Vaccine

2021. 12. 24
SK bioscience and CEPI Expand Partnership to Develop A New Universal Vaccine against variants of SARS-CoV and SARS-CoV-2

2021. 12. 21
SK bioscience Announces New Executive Promotions for 2022

2021. 12. 2
SK bioscience and Korea University Medicine Center Establish Partnership to Respond to Infectious Diseases

2021. 12. 2
SK bioscience Partners with IVI to Launch New Prestigious Award for Vaccine Industry

2021. 11. 30